Postprandial glycaemia: A plea for the frequent use of delta postprandial glycaemia in the treatment of diabetic patients

Diabetes and Metabolism

Volumn 32, Issue 2, 2006, Pages 187-192

  Slama, G ^a   Elgrably, F ^a   Sola, A ^a   Mbemba, J ^a   Larger, E ^a  

^a HÔTEL DIEU   (France)

Author keywords

Alpha glucosidases inhibitors; Glinides; Glycaemic index; Glycated haemoglobin; Postprandial delta glycaemia; Postprandial glycaemic excursion; Postprandial hyperglycaemia; Rapid acting analogs; Self blood glucose monitoring; Slow acting analogs

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE;

BLOOD GLUCOSE MONITORING; DELTA POSTPRANDIAL GLYCEMIA; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

EID: 33645964307     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70268-9     Document Type: Article

References (18)

1. 1c. Diabetes Care 2003;26:881-5
2. 1c measurement improves the detection of type 2 diabetes in high-risk individuals with non-diagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001;24:465-71
3. Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DC, Truswell AS. Low glycaemic index foods improve long-term glycaemic control in NIDDM. Diabetes Care 1991;14:95-101
4. Burge MR, Waters DL, Holcombe JH, Schade DS. Prolonged efficacy of short acting insulin lispro in combination with human ultralente in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:920-4
5. Toeller M. Inhibiteurs de l'alpha-glucosidase. Journ Annu Diabetol Hôtel-Dieu 1991, p. 203-12
6. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83
7. Chiasson JL, Josse RG, Hanefeld M, Karasik A, Laakso M. STOP NIDDM trial research group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-7
8. Derosa G, Mugellini A, Ciccarelli L, Crescenzi G, Fogari R. Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomised, double-blind assessment of metabolic parameters and cardiovascular risk factor. Clin Ther 2003;25:472-84
9. Bornet FRJ, Haardt MJ, Costagliola D, Blayo A, Slama G. Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in type 2 diabetic patients. Diabetologia 1985;28:213-7
10. Rizkalla SW, Weissbrodt P, Slama G, Tchobroutsky G. Insulin receptor changes in type 2 diabetes atter short term insulin treatment. Horm Metab Res 1985;17:512-7
11. Poynard T, Slama G, Tchobroutsky G. Reduction of post-prandial insulin needs by pectin as assessed by the artificial pancreas in insulin-dependent diabetics. Diabetes Metab 1982;8:187-9
12. Bouché C, Rizkalla SW, Luo J, et al. Five-week low glycaemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 2002;25:822-8
13. Kabir M, Oppert JM, Vidal H, et al. Four-week low-glycaemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 2002;51:819-26
14. Rizkalla SW, Taghrid L, Laromiguière M, et al. Improved plasma glucose control, whole-body glucose utilization and lipid profile on a low-glycaemic index diet in Type 2 diabetic men. Diabetes Care 2004;27:1866-72
15. Slama G. Stratégie de conseils diététiques dans le diabète de type II. Quand le conseil «standard» a échoué. Journ Annu Diabetol Hotel Dieu 1998, 71-80
16. Berger W, Grimm JJ. Insulinothérapie : Comment gérer au quotidien les variations physiologiques des besoins en insuline. Masson Ed (Paris), 1999
17. Elgrably F, Sola Gazagnes A, et al. Jeûne ambulatoire de 36 heures pour la détermination des doses de base d'insuline avec auto-apprentissage intensifié ambulatoire : étude chez 27 patients diabétiques de type 1 (DT1) sélectionnés. Diabetes Metab 2004; 1S13 [Abstract]
18. Sachon C, Heurtier A, Grimaldi A. L'insulinothérapie dite «fonctionnelle». Diabetes Metab 1998;24:556-9